JP2524814B2 - Method for producing α-hydroxy-β-amino acid - Google Patents

Method for producing α-hydroxy-β-amino acid

Info

Publication number
JP2524814B2
JP2524814B2 JP63210992A JP21099288A JP2524814B2 JP 2524814 B2 JP2524814 B2 JP 2524814B2 JP 63210992 A JP63210992 A JP 63210992A JP 21099288 A JP21099288 A JP 21099288A JP 2524814 B2 JP2524814 B2 JP 2524814B2
Authority
JP
Japan
Prior art keywords
amino
formula
group
hydroxy
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63210992A
Other languages
Japanese (ja)
Other versions
JPH0259545A (en
Inventor
邦和 酒井
恭子 高橋
孜郎 寺島
大英 常本
哲聖 上條
弘 原田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Original Assignee
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute filed Critical Sagami Chemical Research Institute
Priority to JP63210992A priority Critical patent/JP2524814B2/en
Publication of JPH0259545A publication Critical patent/JPH0259545A/en
Application granted granted Critical
Publication of JP2524814B2 publication Critical patent/JP2524814B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、一般式(I) (式中、Rはアミノ基の保護基である)で表される2−
アミノアルデヒド誘導体に塩基触媒存在下ニトロメタン
を作用させ、一般式(II) (式中、Rはアミノ基の保護基である)で表される3−
アミノ−2−ヒドロキシ−1−ニトロブタン誘導体を
得、次いで酸処理することからなる、式(III) で表されるα−ヒドロキシ−β−アミノ酸誘導体を製造
する方法に関する。一般式(III)で表される化合物
は、すぐれたヒトレニン阻害活性を有し、経口投与が可
能な高血圧治療薬として有用な式(IV) (式中、HisはL−ヒスチジル基である)で表される化
合物(特開昭62−234071参照)を製造する上で重要な原
料となるものである。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention provides a compound represented by the general formula (I): (In the formula, R is an amino-protecting group)
Nitromethane is allowed to act on an aminoaldehyde derivative in the presence of a base catalyst to give a compound of general formula (II) (In the formula, R is a protecting group for an amino group)
Formula (III) consisting of obtaining an amino-2-hydroxy-1-nitrobutane derivative, followed by acid treatment. And a method for producing an α-hydroxy-β-amino acid derivative represented by: The compound represented by the general formula (III) has excellent human renin inhibitory activity and is useful as an orally administrable antihypertensive drug of the formula (IV) (In the formula, His is an L-histidyl group) and is an important starting material for producing a compound (see JP-A-62-234071).

〔従来の技術〕[Conventional technology]

前記一般式(III)で表される化合物は、2−フェニ
ルアラニンより誘導される一般式(I) (式中、Rはアミノ基の保護基である)で表される化合
物にシアン化ナトリウムやシアン化カリウム等を酸の存
在下に付加反応させ、シアンヒドリンとした後、塩酸等
の酸を用いて加水分解を行うことにより得ることができ
る(特開昭62−234071)。
The compound represented by the general formula (III) is a compound represented by the general formula (I) derived from 2-phenylalanine. A compound represented by the formula (wherein R is a protecting group for an amino group) is subjected to an addition reaction with sodium cyanide, potassium cyanide or the like in the presence of an acid to give cyanohydrin, which is then hydrolyzed with an acid such as hydrochloric acid. Can be obtained (JP-A-62-234071).

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

前記従来法は、式(III)で表されるような物質を製
造する上において一般的に行われているものであるが、
溶媒抽出や洗浄、乾燥等の操作を含んでいる。これらの
操作は廃棄物を増やすことになるがシアン化合物の場合
には後処理を繁雑にする要素となるので、シアン化合物
を用いない簡便な方法が求められている。
The above-mentioned conventional method is generally performed for producing a substance represented by the formula (III),
It includes operations such as solvent extraction, washing, and drying. These operations increase the amount of waste, but in the case of a cyanide compound, it becomes an element that complicates the post-treatment, so a simple method without using a cyanide compound is required.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者らはこの点を解決すべく鋭意検討を加えた結
果、下記の反応式に示す簡便な方法の開発に成功し、本
発明を完成させた。
As a result of intensive studies to solve this problem, the present inventors have succeeded in developing a simple method represented by the following reaction formula and completed the present invention.

本発明に用いられる原料となる式(I)の化合物は、
L−フェニルアラニンメチルエステル塩酸塩より容易に
誘導することができる(下記参考例参照)。
The compound of formula (I) used as a raw material in the present invention is
It can be easily induced from L-phenylalanine methyl ester hydrochloride (see the reference example below).

このようにして用意された一般式(I)の化合物は光
学活性体であり、その立体配置は(2S)である。また一
般式(I)の化合物より得られる一般式(II)で表され
るニトロ化合物は、酸処理により容易に式(III)のα
−ヒドロキシ−β−アミノ酸に誘導できる重要な中間体
である。一般式(II)の化合物の立体配置は(2R,3S)
体と(2S,3S)体との混合物である。式(III)で表され
る化合物の立体配置は(2R,3S)体が望ましいが、(2R,
3S)体と(2S,3S)体との混合物であっても一向にさし
つかえない。
The compound of the general formula (I) thus prepared is an optically active substance, and its configuration is (2S). Further, the nitro compound represented by the general formula (II) obtained from the compound of the general formula (I) can be easily treated with an acid to form α of the formula (III).
-A key intermediate that can be derivatized to hydroxy-β-amino acids. The configuration of the compound of general formula (II) is (2R, 3S)
It is a mixture of the body and the (2S, 3S) body. The configuration of the compound represented by formula (III) is preferably the (2R, 3S) configuration, but
Even a mixture of (3S) body and (2S, 3S) body can be used.

第1工程 本工程は式(V)で表されるL−フェニルアラニンメ
チルエステル塩酸塩のアミノ基にRで示される保護基を
かけた後、エステル部分を還元し、アルコール体とし、
ついでフェニル基の還元および水酸基の酸化を行うもの
である。
First Step In this step, after applying a protecting group represented by R to the amino group of L-phenylalanine methyl ester hydrochloride represented by the formula (V), the ester portion is reduced to an alcohol form,
Then, the phenyl group is reduced and the hydroxyl group is oxidized.

Rで示されるアミノ基の保護基としては酸性条件下に
除去できるものであれば良く、例えばホルミル基、アセ
チル基、i−プロピルカルボニル基、t−ブチルカルボ
ニル基、ジメチルアミノカルボニル基、エトキシカルボ
ニル基、i−プロピルオキシカルボニル基、t−ブチル
オキシカルボニル基等を挙げることができる。また、こ
れらの保護基は公知の方法により導入することができる
(T.W.Greene,“Protective Groups in Organic Synthe
sis",John−Whiley+Sons,New York,1980,pp 218〜287
参照)。
The protecting group for the amino group represented by R may be any group that can be removed under acidic conditions, and examples thereof include formyl group, acetyl group, i-propylcarbonyl group, t-butylcarbonyl group, dimethylaminocarbonyl group, ethoxycarbonyl group. , I-propyloxycarbonyl group, t-butyloxycarbonyl group and the like. Further, these protecting groups can be introduced by a known method (TW Greene, “Protective Groups in Organic Synthe
sis ", John-Whiley + Sons, New York, 1980, pp 218-287
reference).

エステル部分の還元は、適当な還元剤として例えば塩
化リチウム存在下に水素化ホウ素ナトリウムを作用させ
ることで行える。
Reduction of the ester moiety can be carried out by allowing sodium borohydride to act as a suitable reducing agent, for example, in the presence of lithium chloride.

また、フェニル基の還元は、接触水添によって容易に
行うことができ、触媒としては白金、ロジウム等を用い
ることができる。
Further, the reduction of the phenyl group can be easily carried out by catalytic hydrogenation, and platinum, rhodium or the like can be used as the catalyst.

ついで水酸基の酸化は、例えばジメチルスルホキシド
中に三酸化イオウ−ピリジン錯体とトリエチルアミンを
用いる方法が好適な方法として例示できる(以上参考例
参照)。
Next, for the oxidation of the hydroxyl group, for example, a method of using a sulfur trioxide-pyridine complex and triethylamine in dimethyl sulfoxide can be exemplified as a suitable method (see the above reference examples).

第2工程 本工程は式(I)で表されるアルデヒドに塩基触媒存
在下にニトロメタンを作用させ、ニトロメチル付加体
(II)を得るものである。本工程に用いられる塩基触媒
としては水酸化リチウム、水酸化ナトリウム、水酸化カ
リウム等のアルカリ金属水酸化物、水酸化カルシウム等
のアルカリ土類金属水酸化物、ナトリウムアミド等のア
ルカリ金属アミド類、炭酸ナトリウム、炭酸カリウム等
のアルカリ金属炭酸塩、カリウムメトキシド、カリウム
−t−ブトキシド等のアルカリ金属アルコキシド類、ト
リエチルアミン、ジアザビシクロウンデセン(DBU)等
のアミン類、フッ化カリウム、またはアンバーライト
IRA 400(OH-)等の陰イオン交換樹脂を挙げることがで
きる。塩基の量はアルデヒド(I)に対して0.01〜0.5
当量あれば良いが、約0.05当量用いるのが好適である。
付加するニトロメタンの量は、アルデヒド(I)に対し
て1.0当量あれば良いが、反応を円滑に進めるために、
1.5当量用いるのが好適である。
Second Step This step is a base-catalyzed presence of the aldehyde of formula (I).
Nitromethyl adduct by acting nitromethane under
(II) is obtained. Base catalyst used in this step
As lithium hydroxide, sodium hydroxide,
Alkali metal hydroxides such as lithium, calcium hydroxide, etc.
Alkaline earth metal hydroxide, sodium amide, etc.
Lucari metal amides, sodium carbonate, potassium carbonate, etc.
Alkali metal carbonate, potassium methoxide, potassium
Alkali metal alkoxides such as -t-butoxide,
Liethylamine, diazabicycloundecene (DBU), etc.
Amines, potassium fluoride, or amberlite
IRA 400 (OH-) Anion exchange resins such as
Wear. The amount of base is 0.01 to 0.5 with respect to aldehyde (I).
The amount may be equivalent, but it is preferable to use about 0.05 equivalent.
The amount of nitromethane added is based on the aldehyde (I)
1.0 equivalent is enough, but for smooth reaction,
It is preferred to use 1.5 equivalents.

用いられる溶媒としてはメタノール、エタノール、i
−プロピルアルコール、t−ブチルアルコール、エチル
エーテル、テトラヒドロフラン、ジオキサン、トルエ
ン、ベンゼン、アセトニトリル等を用いることができる
が、ニトロメタンを溶媒として用いることも可能であ
る。これらの溶媒は使用される塩基触媒に応じて適宜選
択されるものである。
The solvent used is methanol, ethanol, i
-Propyl alcohol, t-butyl alcohol, ethyl ether, tetrahydrofuran, dioxane, toluene, benzene, acetonitrile and the like can be used, but nitromethane can also be used as a solvent. These solvents are appropriately selected according to the base catalyst used.

反応温度は−10℃〜50℃で行うことができるが、0℃
〜室温で行うのが簡便である。反応終了後は溶媒抽出や
ろ過によりニトロブタン誘導体(II)を単離することが
できるが、式(III)の化合物を得る時には特に精製の
必要はなく、すぐにつぎの工程に用いることができる。
The reaction temperature may be -10 ° C to 50 ° C, but 0 ° C
~ Conveniently performed at room temperature. After completion of the reaction, the nitrobutane derivative (II) can be isolated by solvent extraction or filtration, but when the compound of the formula (III) is obtained, it does not particularly need to be purified and can be immediately used in the next step.

第3工程 本工程は一般式(II)で表されるニトロブタン誘導体
を酸加水分解してα−ヒドロキシ−β−アミノ酸(II
I)を得るものである。
Third Step In this step, the nitrobutane derivative represented by the general formula (II) is hydrolyzed with an acid to obtain an α-hydroxy-β-amino acid (II
I) is what you get.

用いられる酸としては塩酸、硫酸、リン酸、メタンス
ルホン酸等が挙げられるが、塩酸を用いると生成物(II
I)を塩酸塩として結晶化させることができる利点を持
つので好適である。反応終了後、塩酸溶液は不溶物をろ
別の後、溶媒を留去することにより式(III)の化合物
を塩酸塩として得ることができる。このとき生成物(II
I)は(2R,3S)体と(2S,3S)体との混合物であるが、
もし(2R,3S)体を単独にほしい時には濃縮を結晶が析
出しはじめた所で止め、静置放冷すると(2R,3S)体が
結晶化するのでろ別により得ることができる。
Examples of the acid used include hydrochloric acid, sulfuric acid, phosphoric acid, methanesulfonic acid, and the like. When hydrochloric acid is used, the product (II
It is preferable because it has an advantage that I) can be crystallized as a hydrochloride. After completion of the reaction, the hydrochloric acid solution is filtered to remove insoluble matter, and then the solvent is distilled off to obtain the compound of formula (III) as a hydrochloride. At this time, the product (II
I) is a mixture of (2R, 3S) and (2S, 3S) isomers,
If the (2R, 3S) form is desired alone, the concentration is stopped at the point where crystals start to precipitate, and the (2R, 3S) form crystallizes if left to stand to cool, which can be obtained by filtration.

以下参考例および実施例によりさらに詳しく説明す
る。
A more detailed description will be given below with reference examples and examples.

参考例 1 L−フェニルアラニンメチルエステル塩酸塩25g(116
mmol)をアルゴン雰囲気下において氷冷し、無水テトラ
ヒドロフラン120mlに懸濁した。これにトリエチルアミ
ン16ml(11.6g、11.6mmol、1.0当量)を加え、次いでト
リエチルアミン17.8ml(12.9g、128mmol、1.1当量)と
クロルぎ酸イソプロピル15.6ml(16.8g、128mmol、1.1
当量)を同時に滴下した。氷冷下2.5時間、さらに室温
で2.5時間攪拌後、減圧下に溶媒を留去し、ジエチルエ
ーテル200mlを加え、1規定の塩酸、飽和炭酸水素ナト
リウム水溶液、飽和食塩水で順次洗浄し、無水硫酸ナト
リウムで乾燥後、減圧下に溶媒を留去し、透明油状のN
−(イソプロポキシカルボニル)−L−フェニルアラニ
ンメチルエステル32.1g(定量的)を得た。1 HNMR(CDCl3) δ:1.15(d,6H,J=5.0),3.05(d,2H,J=3.0),3.63
(s,3H),4.40〜5.20(m,3H),7.12(s,5H) 参考例 2 N−(イソプロポキシカルボニル)−L−フェニルア
ラニンメチルエステル32.1g(116mmol)を無水テトラヒ
ドロフラン150mlに溶解し、塩化リチウム14.9g(348mmo
l、3当量)、水素ホウ素ナトリウム13.2g(348mmol、
3当量)を加え、次いでエタノール300mlを加え、室温
で3時間攪拌後、過剰の試薬を酢酸エチルで処理した。
反応液から減圧下に溶媒を留去し、残渣に水、塩酸を加
えてpH2に調製し、ジエチルエーテルで抽出、飽和食塩
水で洗浄し、減圧下に溶媒を留去し、白色のN−(イソ
プロポキシカルボニル)−L−フェニルアラニノール2
8.1g(定量的)を得た。1 HNMR(CDCl3) δ:1.19(d,6H,J=6.0),2.88(d,2H,J=3.5),3.70〜
4.10(m,3H),4.80(brs,1H),4.95(sep,1H,J=6.0),
7.30(s,5H) 参考例 3 N−(イソプロポキシカルボニル)−L−フェニルア
ラニノール17.2g(65mmol)をメタノール44mlに溶解
し、5%ロジウム−アルミナ1.72g(10w/w%)を加えて
水素圧(50kg/cm2〜60kg/cm2)において17時間攪拌し
た。ろ過により触媒を除去し、減圧下に溶媒を留去し、
さらにベンゼンを加えて再度減圧下乾燥し、透明油状の
2S−{N−(イソプロポキシカルボニル)アミノ}−3
−シクロヘキシルプロパノール16.2g(92%)を得た。1 HNMR(CDCl3) δ:1.24(d,6H,J=6.5),0.60〜1.85(m,13H),2.30(b
rs,1H),3.45〜3.70(m,3H),4.68(brs,1H),4.88(se
p,1H,J=6.5) 参考例 4 2S−{N−(イソプロポキシカルボニル)アミノ}−
3−シクロヘキシルプロパノール1.02g(4.2mmol)を約
18℃におき、無水ベンゼン1.5ml(.31g、16.8mmol、4
当量)、無水ジメチルスルホキシド3.1ml(3.41g、43.7
mmol、10当量)、無水トリエチルアミン1.76ml(1.28
g、12.6mmol、3当量)を加え、攪拌しながら内温17℃
にて三酸化イオウ−ピリジン錯塩2.00g(12.6mmol、3
当量)を徐々に加えた。40分反応後、氷水を加え、ジエ
チルエーテルで抽出し、1規定の塩酸、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後、減圧下に溶
媒を留去し、粗生成物1.0gを得た。これをシリカゲルカ
ラムクロマト(展開溶媒ヘキサン/酢酸エチル=8/1)
により精製し、淡黄色油状の2S−{N−(イソプロポキ
シカルボニル)アミノ}−3−シクロヘキシルプロパナ
ール812mg(80%)を得た。1 HNMR(CDCl3) δ:1.26(d,6H,J=6.0),0.85〜1.75(m,13H),4.28(b
rs,1H),4.97(sep,1H,J=6.0),5.03(brs,1H),9.63
(s,1H) 実施例 1 2−S−{N−(イソプロポキシカルボニル)アミ
ノ}−3−シクロヘキシルプロパナール528mg(2.17mmo
l)をエタノール2.2mlに溶解し、アンバーライト IRA4
00 132mg(25w/w%)、ニトロメタン17.5μ(198.7m
g、3.26mmol、1.5当量)を加え、室温で8時間攪拌し
た。これにエチルエーテル5mlを加えてアンバーライト
をろ過により除去後、減圧下溶媒を留去し、1HNMRによ
り反応の終了を確認し、濃塩酸8mlを加えて100℃で20時
間加熱した。次いで反応液を濃縮、室温に放置し、析出
する白色結晶をろ取し、(2R,3S)−3−アミノ−4−
シクロヘキシル−2−ヒドロキシ酪酸塩酸塩165mg(32
%)を得た。1HNMRによる分析の結果はすべて標準品と
一致した。また、ろ液を蒸発乾燥することにより2R体と
2S体の比が1対2.5の混合物である3S−アミノ−4−シ
クロヘキシル−2−ヒドロキシ酪酸塩酸塩313mg(61
%)を得た。
Reference example 1 25 g of L-phenylalanine methyl ester hydrochloride (116
mmol) under ice-cooling under an atmosphere of argon,
Suspended in 120 ml hydrofuran. Triethylami
16 ml (11.6 g, 11.6 mmol, 1.0 equiv.)
Liethylamine 17.8 ml (12.9 g, 128 mmol, 1.1 eq)
Isopropyl chloroformate 15.6 ml (16.8 g, 128 mmol, 1.1
(Equivalent) was added dropwise at the same time. 2.5 hours under ice cooling, room temperature
After stirring for 2.5 hours at room temperature, the solvent was distilled off under reduced pressure and diethyl ether was added.
200 ml of ether is added and 1N hydrochloric acid and saturated sodium hydrogencarbonate are added.
Sequentially wash with an aqueous solution of sodium and saturated saline, and dry with anhydrous sodium sulfate.
After being dried with helium, the solvent was distilled off under reduced pressure to obtain a clear oily N
-(Isopropoxycarbonyl) -L-phenylalani
32.1 g (quantitative) of methyl ester was obtained.1 HNMR (CDCl3) Δ: 1.15 (d, 6H, J = 5.0), 3.05 (d, 2H, J = 3.0), 3.63
(S, 3H), 4.40-5.20 (m, 3H), 7.12 (s, 5H) Reference example 2 N- (isopropoxycarbonyl) -L-phenyla
Ranine methyl ester 32.1 g (116 mmol)
Dissolved in 150 ml of Drofran, 14.9 g of lithium chloride (348 mmo
l, 3 equivalents), sodium borohydride 13.2 g (348 mmol,
3 eq.), Then 300 ml of ethanol, at room temperature
After stirring at rt for 3 h, excess reagent was treated with ethyl acetate.
The solvent was distilled off from the reaction solution under reduced pressure, and water and hydrochloric acid were added to the residue.
PH to 2 and extract with diethyl ether, saturated saline
It was washed with water, the solvent was distilled off under reduced pressure, and white N- (iso
Propoxycarbonyl) -L-phenylalaninol 2
8.1 g (quantitative) was obtained.1 HNMR (CDCl3) Δ: 1.19 (d, 6H, J = 6.0), 2.88 (d, 2H, J = 3.5), 3.70〜
4.10 (m, 3H), 4.80 (brs, 1H), 4.95 (sep, 1H, J = 6.0),
7.30 (s, 5H) Reference example 3 N- (isopropoxycarbonyl) -L-phenyla
Laninol 17.2 g (65 mmol) dissolved in 44 ml methanol
Then, add 5% rhodium-alumina 1.72g (10w / w%)
Hydrogen pressure (50kg / cm2~ 60kg / cm2) For 17 hours
Was. The catalyst was removed by filtration, the solvent was distilled off under reduced pressure,
Benzene was further added and dried again under reduced pressure to obtain a transparent oily substance.
2S- {N- (isopropoxycarbonyl) amino} -3
-16.2 g (92%) of cyclohexyl propanol were obtained.1 HNMR (CDCl3) Δ: 1.24 (d, 6H, J = 6.5), 0.60 to 1.85 (m, 13H), 2.30 (b
rs, 1H), 3.45 to 3.70 (m, 3H), 4.68 (brs, 1H), 4.88 (se
p, 1H, J = 6.5) Reference example 4 2S- {N- (isopropoxycarbonyl) amino}-
About 1.02 g (4.2 mmol) of 3-cyclohexyl propanol
Place at 18 ℃, 1.5 ml of anhydrous benzene (.31 g, 16.8 mmol, 4
Equivalent), 3.1 ml of anhydrous dimethyl sulfoxide (3.41 g, 43.7
mmol, 10 equivalents), 1.76 ml of anhydrous triethylamine (1.28
g, 12.6 mmol, 3 equivalents), and the internal temperature is 17 ° C with stirring.
At sulfur trioxide-pyridine complex 2.00 g (12.6 mmol, 3
Equivalent) was gradually added. After reacting for 40 minutes, add ice water and
Extract with chilled ether, and then add 1N hydrochloric acid and saturated brine.
Next, wash, dry over anhydrous magnesium sulfate, and dissolve under reduced pressure.
The medium was distilled off to obtain 1.0 g of a crude product. This is silica gel
Rum chromatography (developing solvent hexane / ethyl acetate = 8/1)
The product was purified by 2S- {N- (isopropoxy
Cycarbonyl) amino} -3-cyclohexylpropana
812 mg (80%) was obtained.1 HNMR (CDCl3) Δ: 1.26 (d, 6H, J = 6.0), 0.85 to 1.75 (m, 13H), 4.28 (b
rs, 1H), 4.97 (sep, 1H, J = 6.0), 5.03 (brs, 1H), 9.63
(S, 1H) Example 1 2-S- {N- (isopropoxycarbonyl) ami
No} -3-cyclohexylpropanal 528 mg (2.17 mmo
l) is dissolved in 2.2 ml of ethanol and amber light is added. IRA4
00 132mg (25w / w%), Nitromethane 17.5μ (198.7m
g, 3.26 mmol, 1.5 equivalents) and stirred at room temperature for 8 hours
Was. Add 5 ml of ethyl ether to this and add amber light
Is removed by filtration, the solvent is distilled off under reduced pressure,1By HNMR
After confirming the completion of the reaction, add 8 ml of concentrated hydrochloric acid and at 20 ° C at 100 ° C.
Heated for a while. Then, the reaction solution was concentrated and left at room temperature for precipitation.
The resulting white crystals are collected by filtration, and (2R, 3S) -3-amino-4-
Cyclohexyl-2-hydroxybutyrate 165 mg (32
%).1All results of HNMR analysis are as standard
Matched. Also, by evaporating and drying the filtrate,
A mixture of 3S-amino-4-cys is a mixture of 2S-forms having a ratio of 1: 2.5.
Chlohexyl-2-hydroxybutyrate hydrochloride 313 mg (61
%).

C14H26N2O5 1 HNMR(CDCl3) δ:0.96〜1.66(m,13H),1.15(d,6H),3.42〜3.87(m,
2H),4.27〜4.52(m,4H),4.63〜5.05(m,1H) IR(neat):3350,2990,2930,2860,1690,1552,1380cm-1 C10H19NO3HCl1 HNMR(D2O) δ:0.96〜1.02(m,2H),1.13〜1.29(m,3H),1.36〜1.4
5(m,1H),1.62〜1.78(m,1H),3.71(dt,1H,J=3.4,3.
7),4.37(d,1H,J=3.5) IR(KBr disk):3360,3260,3040,2940,2870,1730,1494c
m-1 実施例 2 2−S−{N−(イソプロポキシカルボニル)アミ
ノ}−3−シクロヘキシルプロパナール40.0mg(0.164m
mol)をエタノール0.1mlに溶解し、アンバーライト IR
A400 10.0mg(25w/w%)、ニトロメタン13.3μ(15.1
mg、0.25mmol、1.5当量)を加え、室温で6時間攪拌し
た。エチルエーテル5mlを加えてアンバーライト をろ
過により除去し、減圧下に溶媒を留去した後、濃塩酸0.
5mlを加え、100℃で17時間加熱後、黒褐色の油状不溶物
を除いて反応液を蒸発乾燥し、1HNMRでδ4.40とδ4.45
付近のピークの積分比を測定し、2R体と2S体の比が1.5
対1の混合物である3S−アミノ−4−シクロヘキシル−
2−ヒドロキシ酪酸塩酸塩35.1mg(90%)を得た。
C14H26N2OFive 1 HNMR (CDCl3) Δ: 0.96-1.66 (m, 13H), 1.15 (d, 6H), 3.42-3.87 (m,
2H), 4.27 ~ 4.52 (m, 4H), 4.63 ~ 5.05 (m, 1H) IR (neat): 3350,2990,2930,2860,1690,1552,1380cm-1 CTenH19NO3HCl1 HNMR (D2O) δ: 0.96-1.02 (m, 2H), 1.13-1.29 (m, 3H), 1.36-1.4
5 (m, 1H), 1.62 to 1.78 (m, 1H), 3.71 (dt, 1H, J = 3.4, 3.
7), 4.37 (d, 1H, J = 3.5) IR (KBr disk): 3360,3260,3040,2940,2870,1730,1494c
m-1 Example 2 2-S- {N- (isopropoxycarbonyl) ami
No} -3-cyclohexylpropanal 40.0 mg (0.164 m
mol) in 0.1 ml of ethanol and amber light IR
A400 10.0mg (25w / w%), Nitromethane 13.3μ (15.1
(mg, 0.25mmol, 1.5eq) and stirred at room temperature for 6 hours
Was. Add 5 ml of ethyl ether and add amber light Roast
After removal by filtration, the solvent was distilled off under reduced pressure, and concentrated hydrochloric acid was added.
After adding 5 ml and heating at 100 ℃ for 17 hours, black brown oily insoluble matter
The reaction solution by evaporation to dryness,1Δ4.40 and δ4.45 by HNMR
The integral ratio of the peaks in the vicinity was measured, and the ratio of 2R body and 2S body was 1.5.
3S-amino-4-cyclohexyl-a mixture of 1
35.1 mg (90%) of 2-hydroxybutyric acid hydrochloride was obtained.

実施例 3〜10 アンバーライト IRA 400を触媒とし、実施例2と類
似の条件下に行った反応例を以下にまとめて示す。
Examples 3-10 Amber Light Example 2 and similar using IRA 400 as a catalyst
An example of reactions performed under similar conditions is summarized below.

実施例 11 2S−{N−(イソプロポキシカルボニル)アミノ}−
3−シクロヘキシルプロパナール26mg(0.107mmol)を
エタノール0.1mlに溶解し、10%水酸化ナトリウム水溶
液2.5μ(0.05当量)、ニトロメタン8.7μ(9.9m
g、0.161mmol、1.5当量)を加え、室温で13時間攪拌し
た。反応後にエチルエーテル5mlを加えて飽和食塩水で
洗い、無水硫酸マグネシウムで乾燥後、減圧下に溶媒を
留去した。これに濃塩酸0.5mlを加え、100℃で17時間加
熱後、黒褐色の油状不溶物を除いて反応液を蒸発乾燥
し、2R体と2S体の比が1.8対1の混合物である3S−アミ
ノ−4−シクロヘキシル−2−ヒドロキシ酪酸塩酸塩2
0.2mg(79%)を得た。
Example 11 2S- {N- (isopropoxycarbonyl) amino}-
26 mg (0.107 mmol) of 3-cyclohexylpropanal was dissolved in 0.1 ml of ethanol, and 2.5 μ (0.05 equivalent) of 10% sodium hydroxide aqueous solution and 8.7 μ (9.9 m of nitromethane).
g, 0.161 mmol, 1.5 eq) was added and stirred at room temperature for 13 hours. After the reaction, 5 ml of ethyl ether was added, the mixture was washed with saturated saline, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. 0.5 ml of concentrated hydrochloric acid was added to this, and after heating at 100 ° C for 17 hours, the black brown oily insoluble matter was removed and the reaction solution was evaporated to dryness to give 3S-amino which is a mixture of the 2R form and the 2S form in a ratio of 1.8: 1. -4-Cyclohexyl-2-hydroxybutyric acid hydrochloride 2
0.2 mg (79%) was obtained.

実施例12〜23 塩基触媒を変えたほかは実施例11と同様に行った反応
例を以下に示す。
Examples 12 to 23 Examples of reactions performed in the same manner as in Example 11 except that the base catalyst is changed are shown below.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 原田 弘 長野県東筑摩郡四賀村大字中川8054番地 審査官 脇村 善一 (56)参考文献 特開 昭63−22081(JP,A) 特開 昭54−36226(JP,A) 英国特許出願公開2200115(GB,A) 欧州特許出願公開22310(EP,A) ─────────────────────────────────────────────────── ─── Continuation of front page (72) Inventor Hiroshi Harada 8054 Nakagawa, Shiga-mura, Higashichikuma-gun, Nagano Examiner Zenichi Wakimura (56) Reference JP-A-63-22081 (JP, A) JP-A-54- 36226 (JP, A) UK patent application publication 2200115 (GB, A) European patent application publication 22310 (EP, A)

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】一般式 (式中、Rはアミノ基の保護基である)で表される2−
アミノアルデヒド誘導体に、塩基触媒存在下ニトロメタ
ンを作用させ、一般式 (式中Rはアミノ基の保護基である)で表される3−ア
ミノ−2−ヒドロキシ−1−ニトロブタン誘導体を得、
次いで酸処理することからなる式 で表されるα−ヒドロキシ−β−アミノ酸誘導体の製造
方法
1. A general formula (In the formula, R is an amino-protecting group)
Aminoaldehyde derivatives are treated with nitromethane in the presence of a base catalyst to give a general formula A 3-amino-2-hydroxy-1-nitrobutane derivative represented by the formula (wherein R is an amino-protecting group),
Then the formula consisting of acid treatment Method for producing α-hydroxy-β-amino acid derivative represented by
JP63210992A 1988-08-25 1988-08-25 Method for producing α-hydroxy-β-amino acid Expired - Lifetime JP2524814B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63210992A JP2524814B2 (en) 1988-08-25 1988-08-25 Method for producing α-hydroxy-β-amino acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63210992A JP2524814B2 (en) 1988-08-25 1988-08-25 Method for producing α-hydroxy-β-amino acid

Publications (2)

Publication Number Publication Date
JPH0259545A JPH0259545A (en) 1990-02-28
JP2524814B2 true JP2524814B2 (en) 1996-08-14

Family

ID=16598532

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63210992A Expired - Lifetime JP2524814B2 (en) 1988-08-25 1988-08-25 Method for producing α-hydroxy-β-amino acid

Country Status (1)

Country Link
JP (1) JP2524814B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0657415B1 (en) * 1993-06-29 1999-09-08 Kaneka Corporation Method of producing 3-amino-2-hydroxy-4-phenyl-butyric acid derivatives and 3-amino-1-nitro-4-phenyl-2-butanol intermediates
EP1159253A2 (en) * 1999-02-23 2001-12-05 Johnson Matthey Pharmaceutical Materials Inc Synthesis of nitroalcohol diastereomers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2200115A (en) 1987-01-21 1988-07-27 Sandoz Ltd Resin inhibitators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5436226A (en) * 1977-08-23 1979-03-16 Sagami Chem Res Center Preparation of derivative of phenyl acetic acid
PH14982A (en) * 1979-06-14 1982-03-05 Beecham Group Ltd 3-nitro-1-phenyl-1-(n-chlorophenyl)-propan-2-ol
JPS6322081A (en) * 1986-07-11 1988-01-29 Kissei Pharmaceut Co Ltd Novel amino acid derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2200115A (en) 1987-01-21 1988-07-27 Sandoz Ltd Resin inhibitators

Also Published As

Publication number Publication date
JPH0259545A (en) 1990-02-28

Similar Documents

Publication Publication Date Title
JP2691442B2 (en) Novel proline derivative
JP2524814B2 (en) Method for producing α-hydroxy-β-amino acid
AU761721B2 (en) Method for producing enantiomer-free N-methyl-N- ((1S)-1-phenyl- 2-((3S)- 3-hydroxypyrrolidine- 1-yl)ethyl)- 2,2-diphenyl acetamide
HU229188B1 (en) Process for the preparation of n-[(s)-1-carboxybutyl]-(s)-alanine esters and their use for synthesizing perindopril
CA2072237A1 (en) Stereoselective production of hydroxyamide compounds from chiral –-amino epoxides
KR20000065019A (en) Improved manufacturing method of enantiomerically pure azetidine-2-carboxylic acid
EP0341462B1 (en) Diastereoselective process for the preparation of intermediates useful for the synthesis of peptide derivatives
JP2006525294A (en) Process for producing 4-hydroxyisoleucine and its derivatives
JP4143787B2 (en) Method for producing α-aminohalomethyl ketone derivative
US5939554A (en) Diarylaminopropanediol and diarylmethyl-oxazolidinone compounds
AU2002220696B2 (en) Process for preparing distamycin derivatives
JP2003509504A (en) Synthetic method of ritonavir
JP3204368B2 (en) Preparation of optically active amides
JP3140698B2 (en) Production method and purification method of 4-hydroxy-2-pyrrolidinone
JP3216673B2 (en) Method for producing 3-hydroxyisoxazole
JPH08259519A (en) Production of alpha-aminoglycol and intermediate thereof
JPS6254791B2 (en)
CA2236117C (en) Process for producing optically active cyanohydrins
EP1078919B1 (en) Synthesis of alpha-amino-alpha',alpha'-dihaloketones and process for the preparation of beta)-amino acid derivatives by the use of the same
JP2825608B2 (en) Optically active threo-3-amino-2-hydroxypentanoic acid and process for producing the same
JP2786300B2 (en) Stereoselective process for producing optically active S, S- or R, R-β-amino alcohols
US5959141A (en) 1-amino-2-hydroxycycloalkanecarboxylic acid derivatives
JPH0217165A (en) (2s,3r)-3-amino-2-acyloxy-4-phenylbutyronitrile derivative and production thereof
JP2921933B2 (en) Optically active butyric acid derivative
HU214581B (en) N2-(1s)-(1-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoro-acetyl-l-lysyl-l-proline-benzilester and process for producing it